Scancell Signs Agreement with Major International Biotechnology Company to Evaluate an Antibody in the Glymab® Portfolio To download click here Wednesday 12 June 2024 16:45 Categories: GlyMab News Regulatory News Year - 2024 Previous Post << >> Next Post